• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Newsletters » The CenterWatch Monthly

The CenterWatch Monthly Subscribe

September 1, 2023

View Archived Issues

Download Current Issue:

  • September 2023 (Vol. 30, Issue 09)
Diversity-DifferentColors-360x240.gif

FDA, Experts Talk Today’s Diversity Challenges in Oncology and Pathways Forward

Diversity has become ingrained as a priority in the oncology space, but industry could get stuck discussing existing barriers without formulating clear plans for taking action. FDA Oncology Center of Excellence (OCE) officials, sponsors and the American Association for Cancer Research (AACR) discuss these hurdles and potential next steps at length in a recent Clinical Cancer Research journal article. Read More

Site Spotlight: Revival Research Takes Screening to the Street at Outdoor Art Fair

Art and clinical trials proved a winning combination when Revival Research Institute took its screening operation to the largest art fair in the U.S. and returned with results that far exceeded everyone’s expectations. Read More

Delving Deeper Into the Draft ICH E6(R3)

In this blog post from WCG Avoca, a collaborative founded with the joint objective of elevating clinical trial quality and bringing key stakeholders in the clinical trial process into greater alignment, Karen Harvey, senior director of the Avoca Quality Consortium, outlines the new ICH draft guideline’s changes to investigator and sponsor responsibilities as well as the newly added data governance section. Read More

Understanding Why Sponsors are ‘Re-Thinking’ DCT Adoption

In this guest column, Ken Getz, Professor and Executive Director, Tufts Center for the Study of Drug Development, presents data-driven insights into why adoption of decentralized trial (DCT) methods is lagging. Read More

Study Lead Opportunities

New Study Lead Opportunities from Apogee Therapeutics, Hansa Biopharma and Neumora Therapeutics. Read More

FDA Actions

New FDA Actions from Artiva Biotherapeutics, ImPact Biotech and Tarsus Pharmaceuticals. Read More

Upcoming Events

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 25Oct

    2023 WCG Patient Forum

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

Featured Products

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

  • Best Practices for Clinical Trial Site Management

    Best Practices for Clinical Trial Site Management

Featured Stories

  • Donna Snyder

    New WCG Executive Physician Outlines Goals for Clinical Research

  • Hand Shake at Meeting

    Partnership to Bolster Trials in Low Resource Regions Kicks Off

  • Guidelines-360x240.png

    Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Monitoring

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing